Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 22;15(3):e247867.
doi: 10.1136/bcr-2021-247867.

Toxic hepatitis-associated aplastic anaemia after dual homeopathic remedies and Gymnema sylvestre use

Affiliations
Case Reports

Toxic hepatitis-associated aplastic anaemia after dual homeopathic remedies and Gymnema sylvestre use

Cyriac Abby Philips et al. BMJ Case Rep. .

Abstract

Hepatitis-associated aplastic anaemia (HAAA) is a rare condition characterised by onset of acute hepatitis which is followed by development of severe pancytopenia due to bone marrow failure within 6 months. This syndrome can be precipitated by acute viral infections, but the aetiology remains unknown in the majority. Drug-induced HAAA is extremely rare and has been reported with nutritional and dietary supplements in current literature. We report the first cases of ayurvedic herbal and homeopathic remedies-associated HAAA in two patients which proved fatal in both. Evaluation of patients with acute hepatitis and severe pancytopenia must include a detailed evaluation for complementary and alternative medicine use.

Keywords: drugs and medicines; gastrointestinal system; hepatitis other; liver disease; toxicology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Retrieved homeopathic remedies (A) and Gymnema sylvestre powder (B) from patients who developed acute hepatitis-associated aplastic anaemia.
Figure 2
Figure 2
Liver histopathology—showing areas of lobular disarray, predominant lobular inflammation (A, H&E 10×); lymphocytic inflammation of the lobular and perisinusoidal areas (B, H&E 40×); hepatocyte fallout (cytolysis) and necrosis in zone 3 (C, H&E, 40×); spotty necrosis and lobular disarray in second patient (D, H&E 10×); intracanalicular (E) and hepatocellular cholestasis (F) noted in second patient (H&E, 100×); bone marrow biopsy showing hypocellularity and trilineage hypoplasia without haemophagocytosis or fibrosis, consistent with aplastic anaemia.

Similar articles

Cited by

References

    1. Rauff B, Idrees M, Shah SAR, et al. . Hepatitis associated aplastic anemia: a review. Virol J 2011;8:87. 10.1186/1743-422X-8-87 - DOI - PMC - PubMed
    1. Locasciulli A, Bacigalupo A, Bruno B, et al. . Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of the EBMT aplastic anaemia Working Party. Br J Haematol 2010;149:890–5. 10.1111/j.1365-2141.2010.08194.x - DOI - PubMed
    1. Cudillo L. Aplastica anemia and viral hepatitis. Mediterr J Hematol Infect Dis 2009;1:e2009026. 10.4084/MJHID.2009.026 - DOI - PMC - PubMed
    1. Alshaibani A, Dufour C, Risitano A, et al. . Hepatitis-associated aplastic anemia. Hematol Oncol Stem Cell Ther 2020;336. 10.1016/j.hemonc.2020.10.001 - DOI - PubMed
    1. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990;11:272–6. 10.1016/0168-8278(90)90124-a - DOI - PubMed

Publication types

MeSH terms